Recent Advances in Primary Immunodysregulation Disorders (RAPID)
Date: May 09, 2024 - May 10, 2024
Overview
The in-person conference explores the topic of primary/genetic immune dysregulation from a multidisciplinary perspective, in collaboration with the MENAT-NIAID initiative. This marks the inaugural primary Immune Dysregulation conference to be hosted by Sidra Medicine in the State of Qatar. The lineup of invited speakers and the scientific committee comprises global authorities in the field, specifically featuring experts from the MENA region and the National Institutes of Allergy and Infectious Diseases (NIAID).
Physicians and scientists who are interested in this area are warmly welcomed to register. Registration is free but will be limited, so be sure to register as soon as possible to reserve a seat. This conference is most suited to basic/clinical researchers who are active in the field, and clinicians who take care of patients with inborn errors of immunity (IEI), also known as primary immunodeficiencies (PID). The event will also be of interest to physicians from a range of specialties who provide clinical care for these patients, including Gastroenterology, Hematology/Oncology, Pathology, Pulmonology, and Rheumatology. The conference will provide the latest updates for all those who wish to stay abreast of clinical and research developments in the field.
Topics/Sessions
- Primary Immunodeficiency spectrum: What is new
- Diagnostic challenges in Inborn Errors of Immunity (IEI)
- Genetic screening for IEI in the MENAT region
- Clinical Presentations of Organ-based Immune Dysregulation
- Immune Dysregulation Disorders: Emerging Therapeutic Strategies and Modalities
- Recent Advances in Corrective Therapies for Inborn Errors of Immunity (IEI)
- Pro & Con Discussions: Curative therapies vs pharmacotherapy in inborn errors of immunity
Conference Objectives
- To improve early recognition and diagnosis of genetic Immune Dysregulation/Immune Deficiency disorders in the MENAT region
- To illustrate the contribution of a range of clinical/pathology specialties and research to the diagnosis and management of Immune Dysregulation
- To provide an update on advances in cutting-edge and translational research in Immune Dysregulation
- To showcase contributions from MENAT researchers to the investigation and management of Immune Dysregulation disorders
Target Audience
- Clinicians and scientists who treat or study patients with primary/genetic immune dysregulation disorders.
Reward Credits CPD
- Not available
If you have any questions about the conference, email rhamada@sidra.org